Skip to main content
. 2019 Mar 3;2019:6567850. doi: 10.1155/2019/6567850

Table 4.

Comparison of demographic, clinical, and laboratory screening variables at the end of three months.

Survivors (n =26) Nonsurvivors (n = 22) p value

Demographic
 Age 55.3 (±12.1) 54.1 (±9.5) 0.726
 Men 17 (65.4%) 16 (72.7%) 0.584
 Women 9 (34.6%) 6 (33.3%)
Clinical
Child-Pugh 9.7(±2.1) 10.9(±1.8) 0.046
MELD 19.3 (±6.1) 24.6 (±7.6) 0.012
MELD-Na 21.7 (±6.6) 27.5 (± 6.2) 0.03
ICA-AKI Stage
 1 17 (65.4%) 10 (56.3%) 0.259
 2 6 (23.1%) 10 (45.5%)
 3 3 (11.5%) 2 (9.1%)
Subdivision of stage 1 (n=28)
 1a 5 (29.4%) 2 (20%) 0.678
 1b 12 (70.6%) 8 (80%)
AKI causes
Infection 10 (38.5%) 10 (45.5%) 0.058
Hypovolemia 9 (34.6%) 6 (27.3%)
Hepatorenal syndrome 0 4 (18.2%)
Nephropathy 2 (7.7%) 0
Miscellaneous 1 (3.8%) 2 (9.1%)
Multiple 4 (15.4%) 0
Response to expansion treatment <0.0001
 Complete 20 (76.9%) 7 (31.8%)
 Partial 5 (19.2%) 3 (13.6%)
 Absent 1 (3.8%) 12 (54.5%)
Encephalopathy
Present 6 (23.1%) 7 (31.8%) 0.361
Absent 20 (76.9%) 15 (68.2%)
Ascites
 Present 21 (80.8%) 12 (90.9%) 0.532
 Absent 5 (19.2%) 2 (9.1%)
Laboratory
 Creatinine (mg/dL) 2.0(±0.9) 2.2(±2.2) 0.525
 Total bilirrubin (mg/dL) 1.6 (0.3-15.2) 5 (0.4-23.9) 0.020
 Albumin (g/dL) 2.4 (±0.5) 2.6 (±0.5) 0.368
 INR 1.5(1-3) 1.9(1.1-7) 0.067
 Sodium (mEq/L) 134.1 (±5.2) 133.4 (±5.2) 0.681
 C-Reactive Protein (mg/L) 30.4 (5-278) 31.6(5-278) 0.869

ICA-AKI, International Club of Ascites–Acute Kidney Injury.